Why Is Micro-Cap Artelo Biosciences Stock Trading Higher On Monday?
Artelo Biosciences, Inc. (NASDAQ:ARTL) stock is trading higher on Monday, with a session volume of 11.7 million, compared to the average volume of 70.3K, as per data from Benzinga Pro.
The company, which focuses on developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, announced favorable results Monday from its first-in-human study evaluating ART26.12, a novel inhibitor of Fatty Acid Binding Protein 5 (FABP5).
The results affirm a promising safety and pharmacokinetic (PK) profile previously observed in preclinical studies.
The Phase 1 Single Ascending Dose study was designed to assess the safety, tolerability, and pharmacokinetics of ART26.12 in healthy volunteers. The study …